Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands.
Bart, A.G., Scott, E.E.(2018) J Biol Chem 293: 19201-19210
- PubMed: 30254074 
- DOI: 10.1074/jbc.RA118.005588
- Primary Citation of Related Structures:  
6DWM, 6DWN - PubMed Abstract: 
Human cytochrome P450 1A1 (CYP1A1) is an extrahepatic enzyme involved in the monooxygenation of structurally diverse compounds ranging from natural products to drugs and protoxins. Because CYP1A1 has a role in human carcinogenesis, inhibiting its activity may potentially aid in cancer chemoprevention, whereas utilizing CYP1A1's oxidative activity could help selectively activate anticancer prodrugs ...